MicroRNA-96 promotes tumor invasion in colorectal cancer via RECK

18Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Background: miR-96 is reported to inhibit reversion cysteine-rich Kazal motif (RECK), which is associated with tumor invasion, in solid cancer types (e.g. breast cancer, non-small cell lung cancer, esophageal cancer). The purpose of this study is to clarify whether miR-96 is similarly associated with tumor invasion in colorectal cancer. Materials and Methods: We performed western blotting to investigate the expression of RECK when miR-96 mimics or inhibitors were transferred into HCT-116 colorectal cancer cells. The RECK mRNA level was assessed by a reverse transcription polymerase chain reaction. An invasion assay was used to evaluate tumor invasion. Results: The expression of RECK was inhibited by the transfection of miR-96 mimics. RECK mRNA level was reduced by miR-96 mimics and increased by miR-96 inhibitor. In the invasion assay, miR-96 mimics were shown to promote tumor invasion. Conclusion: miR-96 may be associated with tumor invasion through inhibition of RECK expression in colorectal cancer.

Cite

CITATION STYLE

APA

Iseki, Y., Shibutani, M., Maeda, K., Nagahara, H., Fukuoka, T., Matsutani, S., … Ohira, M. (2018). MicroRNA-96 promotes tumor invasion in colorectal cancer via RECK. Anticancer Research, 38(4), 2031–2035. https://doi.org/10.21873/anticanres.12442

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free